These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36139589)

  • 1. Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer.
    Loosen SH; Halpaap J; Labuhn S; Bednarsch J; Alizai PH; Roeth AA; Lang SA; Vucur M; Kather JN; Knoefel WT; Ulmer TF; Neumann UP; Roderburg C; Luedde T
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.
    Loosen SH; Breuer A; Tacke F; Kather JN; Gorgulho J; Alizai PH; Bednarsch J; Roeth AA; Lurje G; Schmitz SM; Brozat JF; Paffenholz P; Vucur M; Ritz T; Koch A; Trautwein C; Ulmer TF; Roderburg C; Longerich T; Neumann UP; Luedde T
    JHEP Rep; 2020 Apr; 2(2):100080. PubMed ID: 32140677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
    Loosen SH; Ulmer TF; Labuhn S; Bednarsch J; Lang SA; Alizai PH; Schneider AT; Vucur M; Neumann UP; Luedde T; Roderburg C
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.
    Roderburg C; Labuhn S; Bednarsch J; Lang SA; Schneider AT; Hammerich L; Vucur M; Ulmer TF; Neumann UP; Luedde T; Loosen SH
    Mediators Inflamm; 2022; 2022():6195004. PubMed ID: 36505756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Golgi protein 73 is a prognostic biomarker of liver transplantation patients.
    Wang Y; Zhang Z; Zou D; Hao Q; Ma X; Wang C; Zhang J; Zhang X; Wang B; Wang X; Yang X
    Int J Clin Exp Pathol; 2017; 10(8):8626-8632. PubMed ID: 31966719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
    Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
    Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma.
    Roderburg C; Loosen SH; Bednarsch J; Alizai PH; Roeth AA; Schmitz SM; Vucur M; Luedde M; Paffenholz P; Tacke F; Trautwein C; Ulmer TF; Neumann UP; Luedde T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
    Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
    Ali OM; El Amin HA; Sharkawy YL; Mohamed Ali AA; Kholef EFM; Elsewify WAE
    Int J Gen Med; 2020; 13():193-200. PubMed ID: 32547160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis.
    Eissa M; Awad S; Barakat S; Saleh A; Rozaik S
    Med J Armed Forces India; 2021 Jul; 77(3):331-336. PubMed ID: 34305287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.
    Ai N; Liu W; Li ZG; Ji H; Li B; Yang G
    Oncol Lett; 2017 Oct; 14(4):3953-3958. PubMed ID: 28943903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients.
    Shan SG; Gao YT; Xu YJ; Huang Y; Zhang Q; Zhai DK; Li JB; Wang FM; Jing X; Du Z; Wang YJ
    Hepatol Res; 2013 Nov; 43(11):1199-210. PubMed ID: 23607749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
    Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
    Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma.
    Shaker MK; Attia FM; Hassan AA; Shedid MM; Aboelmagd MA; Faisal AS
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma.
    Jiao C; Cui L; Piao J; Qi Y; Yu Z
    J Cancer Res Ther; 2018; 14(6):1239-1244. PubMed ID: 30488837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.